Ameritas Investment Partners, Inc. Novavax Inc Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 16,126 shares of NVAX stock, worth $128,846. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,126
Previous 13,839
16.53%
Holding current value
$128,846
Previous $174,000
25.86%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$126 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$94.7 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$89.1 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$61.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$46.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $625M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...